Smoking Relapse Prevention in Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

August 31, 2009

Conditions
SchizophreniaSchizoaffective DisorderSmokers
Interventions
DRUG

bupropion + nicotine patch + nicotine gum or lozenges

Subjects eligible for bupropion were randomized to receive either nicotine patch and bupropion or placebo patch and pill added to CBT for 44 weeks.

DRUG

Placebo pill + placebo patch

Subjects eligible for bupropion were randomized to receive either nicotine patch and bupropion or placebo patch and pill added to CBT for 44 weeks.

Trial Locations (1)

02114

Freedom Trail Clinic, Boston

All Listed Sponsors
lead

North Suffolk Mental Health Association

OTHER

NCT00320697 - Smoking Relapse Prevention in Schizophrenia | Biotech Hunter | Biotech Hunter